Bridging the critical gap between complex genomic data and actual clinical practice, this essential volume delivers the cutting-edge AI methodologies, expert bioinformatics insights, and practical case studies needed to unlock truly personalized medicine.
The intersection of artificial intelligence and pharmacogenomics represents a transformative change in the life sciences industry. Pharmacogenomics, the study of how genetic variations influence an individual’s response to drugs, has long held the promise of enabling personalized treatments that are tailored to the genetic profile of individual patients, improving therapeutic outcomes and minimizing adverse drug reactions. However, the complexity of genomic data, massive scale of information, and challenge of interpreting the intricate relationships between genetic variations and drug responses have impeded the widespread implementation of personalized treatments in clinical practice. This volume explores how AI technologies are transforming personalized medicine by optimizing drug responses based on individual genetic profiles. The book will provide a comprehensive look at the role of AI in advancing pharmacogenomic research and its application in clinical practice, enabling healthcare professionals to predict the most effective and safest drugs for individual patients.
The book will be structured around the application of cutting-edge AI techniques in analyzing genomic data. Each chapter will highlight different aspects of AI-driven pharmacogenomics, from drug development and genetic variant identification to clinical implementation and ethical considerations. Experts from diverse fields, including bioinformatics, pharmacology, and data science, will contribute insights into how AI can be harnessed to analyze large genomic datasets, predict patient-specific drug responses, and overcome existing challenges in precision medicine. This volume will not only provide theoretical knowledge but also offer practical examples, case studies, and methodologies that researchers, clinicians, and healthcare professionals can utilize to enhance pharmacogenomic research and personalize patient care.
Table of Contents:
Preface xv
1 Foundations of Pharmacogenomics: Understanding the Genetic Basis of Drug Response 1
Dhanesh Kumar, Thangiah Sathishkumar, Sarangam Kodati, Venkata Praveen Kumar Vuppala, Rasmi A. and Rajakumar Perumal
1.1 Introduction 2
1.2 Genetics of Drug Response Mechanisms 5
1.3 Clinically Actionable Examples 7
1.4 Implementation Frameworks and Clinical Integration 14
1.5 New Technologies and Emerging Trends 19
1.6 Conclusion 20
2 From Data to Therapy: Artificial Intelligence Applications in Pharmacogenomics 23
Yuvaraj Velusamy, L. Gandhimathi, Shaziya Islam, P. Jyothi, Saranya P. and S. Suresh
2.1 Introduction 24
2.2 Data Foundations in AI-Driven Pharmacogenomics 28
2.3 AI Methodologies in PGx 32
2.4 Translating Data to Therapy: Key AI-Driven PGx Applications 36
2.5 Challenges and Limitations 39
2.6 Future Perspectives 42
2.7 Conclusion 45
3 Machine Learning Approaches for Genomic Data Analysis in Pharmacogenomics 49
Ashwin M., Sreenivas Mekala, V. Arun, Ashish, S. Mathumohan and K. Kaliraj
3.1 Introduction 50Contents vii
3.2 Related Works 51
3.3 Methodology 58
3.4 Results and Discussions 65
3.5 Conclusion 71
4 Deep Learning and Neural Networks: Unlocking Complex Patterns in Genomic Medicine 75
M. Sudharsan, K. Maithili, T. Ravi, Margaret Mary T., M. Rajesh Khanna and P. Eswaran
4.1 Introduction 76
4.2 Related Works 78
4.3 Methodology 81
4.4 Results and Discussions 89
4.5 Conclusion 96
4.6 Future Directions of the Study 96
5 AI-Driven Drug Discovery: Accelerating Therapeutic Innovation through Genomics 101
K. Prakash, Phani Kumar Solleti, Tarak Hussain, Chilukala Mahender Reddy, Margaret Mary T. and P. Arumugam
5.1 Introduction 102
5.2 Related Works 104
5.3 Methodology 107
5.4 Results and Discussions 113
5.5 Conclusion 119
5.6 Future Directions 120
6 Personalized Medicine Through Pharmacogenomics and AI: A Precision Therapeutics Approach 125
Dafik, Anto Lourdu Xavier Raj Arockia Selvarathinam, Priya K. V., Sreeram Indraneel, C. Ambhika and Ruth Ramya Kalangi
6.1 Introduction 126
6.2 Related Works 128
6.3 Methodology 133
6.4 Results and Discussions 139
6.5 Discussion 143
6.6 Conclusion 145
6.7 Future Directions 146
7 Real-World Use Cases of AI in Pharmacogenomic Decision Support Systems 149
Kayal Padmanandam, IsaiVani Mariyappan, Anitha D., Sachin Chandravadan Karad, Pooja P. Raj and Umesh Kumar Lihore
7.1 Introduction 150
7.2 Background and Rationale 153
7.3 Methodology 155
7.5 Discussion 165
7.6 Challenges and Barriers to Implementation 167
7.7 Future Directions 168
7.8 Conclusion 169
8 AI Algorithms for Predicting Drug Response in Diverse Populations: Bridging Pharmacogenomics and Precision Medicine 173
Fathimathul Rajeena P.P., Rahoof P. P. and Sunder R.
8.1 Introduction 174x Contents
8.2 Background 177
8.3 Methodology 180
8.4 Results and Findings 184
8.5 Conclusion 193
9 Artificial Intelligence for Genetic Variant Detection and Interpretation 197
Lokendra Singh Songare, Narendra B. Mustare, Kamepalli Sujatha, Albin Kurian, Aparajita Mukherjee and Umesh Kumar Lilhore
9.1 Introduction 198
9.2 Related Works 200
9.3 Methodology 204
9.4 Results and Findings 208
9.5 Conclusion 215
9.6 Future Directions 216
10 Cardiovascular Pharmacogenomics: Genetic Predictors of Drug Response and Toxicity 219
Sunder R., Shanimol Shajan, S. Anupkant, Donamol Joseph, D. Vetrithangam and Rasmi A.
10.1 Introduction 220
10.2 Related Works 222
10.3 Methodology 225Contents xi
10.4 Results and Findings 227
10.5 Conclusion 236
10.6 Future Directions 236
11 Wearable Devices and Real-Time Pharmacogenomic Monitoring 239
P. Kavitha, Sruthy Sukumaran, Kavya Clare P. Shaji, S. Chinnapparaj, Veeraiyah Thangasamy and Sunder R.
11.1 Introduction 240
11.2 Related Works 242
11.3 Methodology 246
11.4 Results and Findings 248
11.5 General Discussion 253
11.6 Conclusions 254
11.7 Future Directions 255
12 Challenges and Limitations of Applying Artificial Intelligence in Pharmacogenomic Pipelines: Technical, Clinical, and Operational Perspectives 259
Yagyesh Godiyal, Maharani Abu Bakar, S. Madhusudhanan, Kochumol Abraham, Aparajita Mukherjee and Sunder R.
12.1 Introduction 260
12.2 Thematic Analysis of Challenges 262
12.3 Identification of Repeated Patterns, Bottlenecks 269
12.4 Strategies to Minimize these Challenges 272
12.5 Real-World AI Applications in Pharmacogenomics 277
12.6 Conclusion 280
12.7 Future Research Directions 280
13 Ethical Frameworks for Integrating AI in Pharmacogenomics: A Focus on Equity and Justice 285
Ika Hesti Agustin, R. Kannamma, Nallametti Nagarjuna, Sheela S., D. Vetrithangam and Thilagavathi K.
13.1 Introduction 286
13.2 Related Works 288
13.3 Research Design 292
13.4 Results and Findings 295
13.5 Conclusion and Future Work 303
14 The Future of AI in Pharmacogenomics: Trends, Innovations, and Global Perspectives 307
Sanaj M.S., Minnuja Shelly, Asha S., Nor Asilah Wati Abdul Hamid, S. Mathumohan and Sudhir Ramadass
14.1 Introduction 308
14.2 Foundations of AI in Pharmacogenomics 311
14.3 Present Developments in Pharmacogenomics Using AI 313
14.4 Innovations and Emerging Technologies 317
14.5 Global Perspectives and Trends 320
14.6 Challenges and Limitations 322
14.7 Future Directions 323
14.8 Conclusion 324
References 325
Index 329
About the Author :
Umesh Kumar Lilhore, PhD is a Professor at Galgotias University, Greater Noida, India with more than 20 years of experience. He has authored ten books and more than 100 research articles in international journals and filed 50 patents across India and the United Kingdom. His research focuses on network security, computer networking, and the Internet of Things.
Kaamran Raahemifar, PhD is a Professor in the College of Information Sciences and Technology at Penn State University. He has authored and co-authored numerous highly cited publications and books in reputed international journals and conferences. His research focuses on AI-driven healthcare systems, machine learning, optimization, medical image processing, and intelligent smart systems.
Sarita Simaiya, PhD is a Professor at Galgotias University, Greater Noida, India with more than 18 years of experience. She has co-authored several peer-reviewed publications in reputed international journals and conferences, with a focus on integrating emerging AI technologies into healthcare and biomedical research. Her research interests include AI-driven healthcare systems, deep learning models, and intelligent data analytics for biomedical applications.
R. Sunder, PhD is an academician and researcher with expertise in artificial intelligence, machine learning, data analytics, and intelligent healthcare systems. His research interests include AI-driven biomedical applications, computational intelligence, and advanced data processing techniques for healthcare and pharmaceutical domains. He has contributed to interdisciplinary research projects and scholarly publications focused on emerging technologies and digital healthcare innovation.
R. Lotus, PhD is a researcher and academician specializing in artificial intelligence, computational biology, and healthcare technologies. She has contributed to multidisciplinary research initiatives and scholarly publications focused on advancing digital healthcare, precision medicine, and emerging computational technologies. She is actively engaged in promoting innovative AI solutions for healthcare and biomedical research.
